vs
Side-by-side financial comparison of Granite Ridge Resources, Inc. (GRNT) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Granite Ridge Resources, Inc. is the larger business by last-quarter revenue ($105.5M vs $70.6M, roughly 1.5× Viridian Therapeutics, Inc.\DE). On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -0.8%).
Granite Ridge Resources, Inc. is an independent upstream energy company focused on the exploration, development, and production of oil, natural gas, and natural gas liquids. It operates low-cost, high-yield onshore hydrocarbon assets across key U.S. basins, primarily serving North American energy markets.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
GRNT vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $105.5M | $70.6M |
| Net Profit | — | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | -34.5% | -56.7% |
| Net Margin | — | -49.0% |
| Revenue YoY | -0.8% | 81958.1% |
| Net Profit YoY | — | 54.9% |
| EPS (diluted) | $-0.19 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $105.5M | — | ||
| Q3 25 | $112.7M | $70.6M | ||
| Q2 25 | $109.2M | — | ||
| Q1 25 | $122.9M | — | ||
| Q4 24 | $106.3M | — | ||
| Q3 24 | $94.1M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $89.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | $14.5M | $-34.6M | ||
| Q2 25 | $25.1M | — | ||
| Q1 25 | $9.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.1M | — | ||
| Q2 24 | $5.1M | — | ||
| Q1 24 | $16.2M | — |
| Q4 25 | -34.5% | — | ||
| Q3 25 | 17.4% | -56.7% | ||
| Q2 25 | 19.0% | — | ||
| Q1 25 | 34.6% | — | ||
| Q4 24 | -6.5% | — | ||
| Q3 24 | 26.2% | — | ||
| Q2 24 | 24.1% | — | ||
| Q1 24 | 22.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | 12.9% | -49.0% | ||
| Q2 25 | 23.0% | — | ||
| Q1 25 | 8.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 9.6% | — | ||
| Q2 24 | 5.6% | — | ||
| Q1 24 | 18.2% | — |
| Q4 25 | $-0.19 | — | ||
| Q3 25 | $0.11 | — | ||
| Q2 25 | $0.19 | — | ||
| Q1 25 | $0.07 | — | ||
| Q4 24 | $-0.09 | — | ||
| Q3 24 | $0.07 | — | ||
| Q2 24 | $0.04 | — | ||
| Q1 24 | $0.12 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $490.9M |
| Total DebtLower is stronger | $367.8M | — |
| Stockholders' EquityBook value | $605.8M | $503.0M |
| Total Assets | $1.2B | $577.1M |
| Debt / EquityLower = less leverage | 0.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $490.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $367.8M | — | ||
| Q3 25 | $300.0M | — | ||
| Q2 25 | $275.0M | — | ||
| Q1 25 | $250.0M | — | ||
| Q4 24 | $205.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $137.5M | — |
| Q4 25 | $605.8M | — | ||
| Q3 25 | $643.9M | $503.0M | ||
| Q2 25 | $642.5M | — | ||
| Q1 25 | $631.4M | — | ||
| Q4 24 | $635.4M | — | ||
| Q3 24 | $660.6M | — | ||
| Q2 24 | $665.3M | — | ||
| Q1 24 | $674.0M | — |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.1B | $577.1M | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $990.5M | — | ||
| Q1 24 | $966.7M | — |
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.47× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.40× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.20× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $64.5M | $-84.6M |
| Free Cash FlowOCF − Capex | — | $-84.7M |
| FCF MarginFCF / Revenue | — | -120.1% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $64.5M | — | ||
| Q3 25 | $77.8M | $-84.6M | ||
| Q2 25 | $78.0M | — | ||
| Q1 25 | $76.1M | — | ||
| Q4 24 | $68.2M | — | ||
| Q3 24 | $74.7M | — | ||
| Q2 24 | $64.2M | — | ||
| Q1 24 | $68.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $-84.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -120.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.36× | — | ||
| Q2 25 | 3.11× | — | ||
| Q1 25 | 7.75× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.25× | — | ||
| Q2 24 | 12.58× | — | ||
| Q1 24 | 4.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRNT
| Oil And Gas Service | $87.6M | 83% |
| Natural Gas Storage | $17.9M | 17% |
VRDN
Segment breakdown not available.
